Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-04 Sale |
2021-10-06 4:37 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
987 | $101.73 | $100,408 | 14,841 (Direct) |
View |
| 2021-08-16 Sale |
2021-08-18 6:18 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
5,628 | $89.62 | $504,395 | 15,608 (Direct) |
View |
| 2021-07-27 Sale |
2021-07-29 5:32 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
16,709 | $93.8 | $1,567,336 | 15,801 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-14 8:25 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
10,000 | $100.27 | $1,002,743 | 213,697 (Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 8:27 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
1,700 | $119.96 | $203,926 | 54,043 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:42 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
6,370 | $115.65 | $736,702 | 156,839 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 9:30 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
2,910 | $116.82 | $339,942 | 66,940 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:27 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Bozigian Haig P. Chief Development Officer |
4,546 | $116.33 | $528,857 | 161,371 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:26 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
5,079 | $116.38 | $591,089 | 73,170 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:24 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
1,943 | $115.84 | $225,076 | 50,931 (Direct) |
View |
| 2021-02-08 Sale |
2021-02-09 9:21 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
2,363 | $116.78 | $275,944 | 70,764 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:20 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
4,126 | $116.26 | $479,668 | 69,704 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:18 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
3,313 | $116.16 | $384,822 | 129,905 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:17 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
12,888 | $116.26 | $1,498,368 | 573,850 (Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 9:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
40,206 | $116.19 | $4,671,507 | 82,713 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 9:53 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
2,000 | $120.02 | $240,047 | 223,697 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 9:30 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
18,670 | $119.97 | $2,239,777 | 76,568 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 8:58 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
5,477 | $120.02 | $657,371 | 128,451 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:17 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
2,632 | $111.06 | $292,297 | 15,845 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 4:16 pm |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
308,250 | $110.22 | $33,973,877 | 441,071 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-19 Option Award |
2021-05-20 4:12 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Sharp Shalini Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:11 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | RASTETTER WILLIAM H Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | SHERWIN STEPHEN A Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:09 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | POPS RICHARD F Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:08 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Norwalk Leslie V Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:07 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | MORROW GEORGE J Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:06 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | Mercier Johanna Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:03 pm |
2021-06-19 2031-05-19 |
NEUROCRINE BIOSCIENCES INC | NBIX | LYONS GARY A Director |
8,833 | $0 | 8,833 (Direct) |
View |
| 2021-04-15 Option Award |
2021-04-16 4:04 pm |
N/A 2031-04-15 |
NEUROCRINE BIOSCIENCES INC | NBIX | Mercier Johanna Director |
17,180 | $0 | 17,180 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:24 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
49,049 | $0 | 49,049 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:23 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
35,035 | $0 | 35,035 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:22 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
45,546 | $0 | 45,546 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:21 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
42,042 | $0 | 42,042 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:19 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
113,863 | $0 | 113,863 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:15 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
49,049 | $0 | 49,049 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:13 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
35,035 | $0 | 35,035 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-29 06:12 am |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Bozigian Haig P. Chief Development Officer |
3,504 | $0 | 3,504 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-26 9:48 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
49,049 | $0 | 49,049 (Direct) |
View |
| 2021-02-08 Option Award(A) |
2021-03-26 9:48 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
49,049 | $0 | 49,049 (Direct) |
View |
| 2021-02-10 Exercise |
2021-02-12 8:27 pm |
N/A 2026-02-05 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
3,400 | $35.99 | 54,043 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:42 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Gano Kyle Chief Business Development Off |
52,071 | $0 | 156,839 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:30 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ABERNETHY MATT Chief Financial Officer |
52,071 | $0 | 66,940 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:27 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Bozigian Haig P. Chief Development Officer |
3,720 | $0 | 161,371 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:26 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
52,071 | $0 | 73,170 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:24 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Cooke Julie Chief Human Resources Officer |
37,194 | $0 | 50,931 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:21 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | ROBERTS EIRY Chief Medical Officer |
52,071 | $0 | 70,764 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:20 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
37,194 | $0 | 69,704 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:18 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Grigoriadis Dimitri E. Chief Research Officer |
44,632 | $0 | 129,905 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:17 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
120,878 | $0 | 573,850 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-09 9:16 pm |
N/A 2031-02-08 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
48,352 | $0 | 82,713 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-09 9:16 pm |
N/A 2026-02-05 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lippoldt Darin Chief Legal Officer |
72,388 | $35.99 | 82,713 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 9:30 pm |
N/A 2025-02-03 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
8,958 | $32.99 | 76,568 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 9:30 pm |
N/A 2026-02-05 |
NEUROCRINE BIOSCIENCES INC | NBIX | Lloyd-Smith Malcolm Chief Regulatory Officer |
19,424 | $35.99 | 76,568 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 8:58 pm |
N/A 2025-06-01 |
NEUROCRINE BIOSCIENCES INC | NBIX | BENEVICH ERIC Chief Commercial Officer |
3,777 | $41.78 | 128,451 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:16 pm |
N/A 2022-01-12 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
143,449 | $8.66 | 441,071 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-12 4:16 pm |
N/A 2023-01-10 |
NEUROCRINE BIOSCIENCES INC | NBIX | GORMAN KEVIN CHARLES Chief Executive Officer |
164,801 | $8.65 | 441,071 (Direct) |
View |